Outset Medical, Inc. (OM)
NASDAQ: OM · Real-Time Price · USD
3.480
-0.090 (-2.52%)
At close: Mar 3, 2026, 4:00 PM EST
3.480
0.00 (0.00%)
Pre-market: Mar 4, 2026, 5:10 AM EST
Outset Medical Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Outset Medical stock have an average target of 13.33, with a low estimate of 8.00 and a high estimate of 17. The average target predicts an increase of 283.05% from the current stock price of 3.48.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Outset Medical stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Maintains $17 → $15 | Strong Buy | Maintains | $17 → $15 | +331.03% | Feb 12, 2026 |
| Stifel | Stifel | Strong Buy Maintains $14 → $8 | Strong Buy | Maintains | $14 → $8 | +129.89% | Jan 7, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +388.51% | Dec 16, 2025 |
| Stifel | Stifel | Strong Buy Maintains $17 → $14 | Strong Buy | Maintains | $17 → $14 | +302.30% | Nov 11, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $22 → $17 | Hold | Maintains | $22 → $17 | +388.51% | Nov 11, 2025 |
Financial Forecast
Revenue This Year
130.42M
from 119.48M
Increased by 9.16%
Revenue Next Year
145.02M
from 130.42M
Increased by 11.19%
EPS This Year
-2.74
from -5.37
EPS Next Year
-2.47
from -2.74
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 134.1M | 150.6M | |||
| Avg | 130.4M | 145.0M | |||
| Low | 122.6M | 136.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 12.2% | 15.5% | |||
| Avg | 9.2% | 11.2% | |||
| Low | 2.6% | 4.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -2.12 | -2.21 | |||
| Avg | -2.74 | -2.47 | |||
| Low | -3.13 | -2.73 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.